The objective of this study is to evaluate the potential PK interaction between ABT-335,
atorvastatin 80 mg and ezetimibe 10 mg when administered concurrently.
- Healthy male or female subjects
- Clinically significant diseases or disorders
- Positive screens for drug and alcohol
- Pregnant or breast-feeding females
- Any history of surgery(ies) that might interfere with the gastrointestinal motility,
pH or absorption